Wenlei Jiang, Ph.D.

US Food and Drug Administration

Poster(s):

• (T1430-09-62) Characterization of Intravenous Iron Supplements: Injectafer^®
  Tuesday, October 24, 2023

  2:30 PM – 3:30 PM ET

• (M1530-09-60) Doxorubicin HCl Release from Liposomal Doxorubicin Formulations – Autonomous Capillary Electrophoretic (CE) In Vitro Release Test (IVRT) Method
  Monday, October 23, 2023

  3:30 PM – 4:30 PM ET

• (W1130-09-58) Qualitative and Quantitative Analysis of Lipids in Exparel ^® Injectable Liposomal Drug Formulation
  Wednesday, October 25, 2023

  11:30 AM – 12:30 PM ET

• (M1330-06-39) Regulatory Perspective of Considerations in Endogenous Therapeutic Analyte Bioanalysis
  Monday, October 23, 2023

  1:30 PM – 2:30 PM ET